Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar;86(3):256-308.
doi: 10.1016/j.jinf.2022.12.029. Epub 2023 Jan 1.

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population

Jorge Camacho  1 , Joao Zulaica  2 , Estela Giménez  3 , Luciana Rusu  2 , Sebastian Velandia-Álvarez  2 , Eliseo Albert  1 , Salvador Peiró  4 , Hermelinda Vanaclocha  5 , Ramón Limón  6 , Ron Geller  2 , David Navarro  7 ; Valencian Vaccine Research Program (ProVaVac) study group
Affiliations
Comment

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population

Jorge Camacho et al. J Infect. 2023 Mar.
No abstract available

Keywords: COVID-19 vaccines; Covid-19; Neutralizing antibodies; Omicron BA.4/5; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Figures

Fig 1
Fig. 1
Neutralizing antibody (NtAb) responses against Wuhan-Hu-1 and Omicron BA.4/5 as measured using a pseudotyped vesicular stomatitis virus system. (A) Reciprocal NtAb titers against Wuhan-Hu-1 and Omicron BA.4/5 in vaccinated/SARS-CoV-2 experienced (VAC-ex) and vaccinated/SARS-CoV-2 naïve participants (VAC-n). (B) Reciprocal NtAb titers against Wuhan-Hu-1 and Omicron BA.4/5 in vaccinated/SARS-CoV-2 experienced (VAC-ex) participants with SARS-CoV-2 infection documented by RT-PCR. P values for comparisons across groups (Mann-Whitney U test) are shown. A P value <0.05 was deemed as significant. The analyses were performed using SPSS version 20.0 (SPSS, Chicago, IL, USA) and STATA 17.0 (StataCorp, College Station, Texas, USA).
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Dimeglio C., Migueres M., Chapuy-Regaud S., Da-Silva I., Jougla I., Pradere C., et al. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response. J Infect. 2022;85(1):e4–e6. - PMC - PubMed
    1. Cao Y., Yisimayi A., Jian F., Song W., Xiao T., Wang L., et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593–602. - PMC - PubMed
    1. Hachmann N.P., Miller J., Collier A.Y., Ventura J.D., Yu J., Rowe M., et al. Neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387(1):86–88. - PMC - PubMed
    1. Tuekprakhon A., Nutalai R., Dijokaite-Guraliuc A., Zhou D., Ginn H.M., Selvaraj M., et al. Antibody escape of SARS-CoV-2 omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185(14):2422–2433. e13. - PMC - PubMed
    1. Camacho J., Giménez E., Albert E., Zulaica J., Álvarez-Rodríguez B., Torres I., et al. Cumulative incidence of SARS-CoV-2 infection in the general population of the valencian community (Spain) after the surge of the Omicron BA.1 variant. J Med Virol. 2022:e28284. - PMC - PubMed